Chong Kun Dang Pharmaceutical (185750) — Net Asset Quality Index
Chong Kun Dang Pharmaceutical (185750) has a Net Asset Quality Index of 56.2% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of ₩1.83 Trillion minus total liabilities of ₩803.02 Billion yields net assets of ₩1.03 Trillion. A higher index indicates a stronger, lower-leverage balance sheet. See defensive interval ratio of Chong Kun Dang Pharmaceutical to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
Chong Kun Dang Pharmaceutical Net Asset Quality Index Over Time (2016–2025)
This chart shows how Chong Kun Dang Pharmaceutical's Net Asset Quality Index has evolved across 10 annual periods from 2016 to 2025. As of March 2026, the index stands at 56.2%, representing net assets of ₩1.03 Trillion against total assets of ₩1.83 Trillion KRW. Explore Chong Kun Dang Pharmaceutical operating cash flow efficiency to assess how effectively this company generates cash.
Annual Net Asset Quality Index for Chong Kun Dang Pharmaceutical (2016–2025)
The table below presents the year-by-year Net Asset Quality Index for Chong Kun Dang Pharmaceutical from 2016 to 2025, covering 10 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see 185750 market cap overview.
| Year | Quality Index | Net Assets (KRW) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 55.9% | ₩1.01 Trillion | ₩1.80 Trillion | ₩793.94 Billion | ▼ -5.5 pp |
| 2024 | 61.4% | ₩896.38 Billion | ₩1.46 Trillion | ₩562.39 Billion | ▲ +3.3 pp |
| 2023 | 58.2% | ₩815.64 Billion | ₩1.40 Trillion | ₩586.79 Billion | ▲ +2.9 pp |
| 2022 | 55.2% | ₩621.29 Billion | ₩1.12 Trillion | ₩503.59 Billion | ▲ +1.2 pp |
| 2021 | 54.1% | ₩565.81 Billion | ₩1.05 Trillion | ₩480.89 Billion | ▼ -4.2 pp |
| 2020 | 58.3% | ₩551.59 Billion | ₩946.33 Billion | ₩394.74 Billion | ▼ -1.0 pp |
| 2019 | 59.3% | ₩474.95 Billion | ₩801.35 Billion | ₩326.40 Billion | ▼ -1.3 pp |
| 2018 | 60.6% | ₩430.90 Billion | ₩711.49 Billion | ₩280.60 Billion | ▲ +1.0 pp |
| 2017 | 59.6% | ₩403.29 Billion | ₩677.21 Billion | ₩273.91 Billion | ▲ +4.3 pp |
| 2016 | 55.2% | ₩354.25 Billion | ₩641.70 Billion | ₩287.45 Billion | — |